Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel liquefied gas based oral controlled release drug delivery system for liquid drug formulations.
Haznar-Garbacz D, Garbacz G, Eisenächer F, Klein S, Weitschies W. Haznar-Garbacz D, et al. Eur J Pharm Biopharm. 2012 Jun;81(2):334-8. doi: 10.1016/j.ejpb.2012.02.015. Epub 2012 Mar 8. Eur J Pharm Biopharm. 2012. PMID: 22426133
Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.
Haznar-Garbacz D, Kaminska E, Zakowiecki D, Lachmann M, Kaminski K, Garbacz G, Dorożyński P, Kulinowski P. Haznar-Garbacz D, et al. AAPS PharmSciTech. 2018 Feb;19(2):951-960. doi: 10.1208/s12249-017-0912-0. Epub 2017 Nov 2. AAPS PharmSciTech. 2018. PMID: 29098644
Multimodal approach to characterization of hydrophilic matrices manufactured by wet and dry granulation or direct compression methods.
Kulinowski P, Woyna-Orlewicz K, Obrał J, Rappen GM, Haznar-Garbacz D, Węglarz WP, Jachowicz R, Wyszogrodzka G, Klaja J, Dorożyński PP. Kulinowski P, et al. Among authors: haznar garbacz d. Int J Pharm. 2016 Feb 29;499(1-2):263-270. doi: 10.1016/j.ijpharm.2015.12.067. Epub 2016 Jan 2. Int J Pharm. 2016. PMID: 26752087
An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - case study of multimodal characterization of quetiapine fumarate tablets.
Kulinowski P, Woyna-Orlewicz K, Rappen GM, Haznar-Garbacz D, Węglarz WP, Dorożyński PP. Kulinowski P, et al. Among authors: haznar garbacz d. Int J Pharm. 2015 Apr 30;484(1-2):235-45. doi: 10.1016/j.ijpharm.2015.02.040. Epub 2015 Feb 18. Int J Pharm. 2015. PMID: 25701626
An oral-controlled release drug delivery system for liquid and semisolid drug formulations.
Haznar-Garbacz D, Garbacz G, Eisenächer F, Klein S, Weitschies W. Haznar-Garbacz D, et al. AAPS PharmSciTech. 2011 Dec;12(4):1183-5. doi: 10.1208/s12249-011-9689-8. Epub 2011 Sep 15. AAPS PharmSciTech. 2011. PMID: 21918919 Free PMC article.
Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3.
Schönherr D, Wollatz U, Haznar-Garbacz D, Hanke U, Box KJ, Taylor R, Ruiz R, Beato S, Becker D, Weitschies W. Schönherr D, et al. Among authors: haznar garbacz d. Eur J Pharm Biopharm. 2015 May;92:155-70. doi: 10.1016/j.ejpb.2015.02.028. Epub 2015 Mar 7. Eur J Pharm Biopharm. 2015. PMID: 25758123
Studying the Impact of Modified Saccharides on the Molecular Dynamics and Crystallization Tendencies of Model API Nifedipine.
Kaminska E, Tarnacka M, Wlodarczyk P, Jurkiewicz K, Kolodziejczyk K, Dulski M, Haznar-Garbacz D, Hawelek L, Kaminski K, Wlodarczyk A, Paluch M. Kaminska E, et al. Among authors: haznar garbacz d. Mol Pharm. 2015 Aug 3;12(8):3007-19. doi: 10.1021/acs.molpharmaceut.5b00271. Epub 2015 Jul 7. Mol Pharm. 2015. PMID: 26101945
The influence of physical division of tablets on the variability of release kinetics of gliclazide.
Wójcik-Pastuszka D, Biedrawa AM, Haznar-Garbacz D, Musiał WS. Wójcik-Pastuszka D, et al. Among authors: haznar garbacz d. Monatsh Chem. 2018;149(5):953-959. doi: 10.1007/s00706-018-2176-0. Epub 2018 Mar 3. Monatsh Chem. 2018. PMID: 29720769 Free PMC article.
Feedback